Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors
Matthew A. Murray(Yale University), Ranjit S. Bindra(Yale University)
Cited by 6
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869
A whole-animal platform to advance a clinical kinase inhibitor into new disease space
|Nature Chemical Biology|2018|73
Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
|Scientific Reports|2022|23
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion
|Molecular Cancer Research|2024|5